BeOne Medicines
ONC
#651
Rank
$35.73 B
Marketcap
$322.90
Share price
-2.56%
Change (1 day)
55.52%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total debt

Total debt on the balance sheet as of September 2025 : $1.01 Billion USD

According to BeOne Medicines's latest financial reports the company's total debt is $1.01 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

BeOne Medicines - Total debt on balance sheet (from 2014 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$1.07 B16.09%
2023-12-31$0.93 B55.89%
2022-12-31$0.59 B-14.1%
2021-12-31$0.69 B23.61%
2020-12-31$0.56 B102.62%
2019-12-31$0.27 B39.79%
2018-12-31$0.19 B20.45%
2017-12-31$0.16 B852.99%
2016-12-31$17.28 M-16.85%
2015-12-31$20.78 M50.21%
2014-12-31$13.83 M-49.43%
2013-12-31$27.36 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Onconova Therapeutics
ONTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
$0.39 B-61.23%๐Ÿ‡บ๐Ÿ‡ธ USA